Dysautonomia is not a single disease. It is an umbrella term for any condition in which the autonomic nervous system — the network that controls heart rate, blood pressure, digestion, temperature regulation, and dozens of other involuntary functions — fails to work properly. The vagus nerve, carrying roughly 75% of all parasympathetic fibres, is the single largest autonomic nerve in the body. When dysautonomia strikes, vagal dysfunction is almost always part of the picture.
How the Vagus Nerve Fits into Autonomic Control
The autonomic nervous system operates through two complementary branches. The sympathetic branch accelerates the heart, raises blood pressure, and mobilises energy. The parasympathetic branch, dominated by the vagus nerve, slows the heart, lowers blood pressure, and promotes digestion and recovery. In a healthy system, these branches adjust continuously in response to posture changes, meals, exercise, stress, and sleep. Dysautonomia occurs when this dynamic balancing act breaks down.
The vagus nerve contributes to autonomic control through both its efferent (brain-to-body) and afferent (body-to-brain) fibres. Roughly 80% of vagal fibres are afferent — they carry sensory information from the heart, lungs, gut, and other organs back to the nucleus tractus solitarius (NTS) in the brainstem. The NTS integrates this information and coordinates the autonomic response. Damage or dysfunction at any point along this circuit can produce dysautonomia symptoms.
Major Types of Dysautonomia
Postural orthostatic tachycardia syndrome (POTS) is the most commonly diagnosed form in younger adults. The diagnostic criterion is a sustained heart rate increase of 30 beats per minute or more (40 bpm in adolescents) within 10 minutes of standing, without a corresponding drop in blood pressure. POTS is not a single entity — recognised subtypes include neuropathic (partial autonomic denervation, often in the lower limbs), hyperadrenergic (excessive noradrenaline release on standing), and hypovolaemic (reduced blood volume). An autoimmune subtype, in which antibodies target autonomic receptors, has gained increasing recognition. Vagal involvement in POTS is evident in the reduced heart rate variability (HRV) consistently observed in these patients, reflecting impaired cardiac vagal modulation.
Vasovagal syncope (neurocardiogenic syncope) is the most common cause of fainting, accounting for roughly 50% of all syncope episodes. The mechanism involves an inappropriate vagal surge — the brainstem triggers sudden parasympathetic activation, causing bradycardia and vasodilation, which drops blood pressure and cerebral perfusion. Triggers include prolonged standing, heat, blood draws, pain, and emotional stress. Tilt table testing can reproduce the response under controlled conditions.
Diabetic autonomic neuropathy affects up to 50% of people with long-standing diabetes. Chronically elevated blood glucose damages small nerve fibres, including vagal fibres. Cardiac vagal denervation is often the earliest detectable autonomic abnormality — resting tachycardia and loss of normal heart rate variability appear before symptoms become obvious. Gastroparesis (delayed gastric emptying) is another hallmark, reflecting damage to vagal motor fibres supplying the stomach.
Multiple system atrophy (MSA) is a rare, progressive neurodegenerative condition affecting both autonomic and motor systems. Unlike most forms of dysautonomia, MSA involves central neurodegeneration — loss of neurons in the brainstem autonomic nuclei, including those that generate vagal output. Severe orthostatic hypotension, urinary dysfunction, and progressive motor impairment characterise the condition.
Autoimmune autonomic ganglionopathy (AAG) is caused by antibodies against the ganglionic acetylcholine receptor, which disrupts transmission in both sympathetic and parasympathetic ganglia. Patients present with widespread autonomic failure — orthostatic hypotension, anhidrosis, gastroparesis, and dry eyes and mouth. Antibody titres correlate with disease severity, and immunotherapy can produce significant improvement.
Pure autonomic failure (PAF) involves degeneration of peripheral autonomic neurons without the motor features seen in MSA. Patients develop progressive orthostatic hypotension and other autonomic symptoms while retaining normal movement and cognition, though a proportion eventually convert to MSA or Parkinson’s disease.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- Polyvagal-informed therapy
- Somatic therapy
- HRV biofeedback
- Craniosacral therapy
- Breathwork
- Insomnia therapy (CBT-I)
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
Post-COVID Dysautonomia
The COVID-19 pandemic brought dysautonomia to wider attention. Studies from Spain by Llados and colleagues, examining over 300 long-COVID patients, found that approximately two-thirds had symptoms consistent with vagal dysfunction — tachycardia, gastrointestinal disturbance, voice changes, and dysphagia. Around 20% showed vagus nerve thickening on ultrasound, and approximately 40% had diaphragm flattening suggestive of phrenic or vagal involvement. The mechanisms likely include direct viral neurotropism, post-infectious autoimmune attack on autonomic structures, and microclot-related ischaemia of small nerve fibres.
POTS has been the most frequently diagnosed dysautonomia subtype in long-COVID patients. The autoimmune hypothesis is supported by the detection of various autoantibodies — against adrenergic receptors, muscarinic receptors, and other autonomic targets — in a substantial proportion of post-COVID POTS cases.
Diagnosing Vagal Dysautonomia
Assessment typically begins with bedside cardiovascular reflex testing. The deep breathing test measures heart rate variation during slow paced breathing at six cycles per minute — a direct test of cardiac vagal function. The Valsalva ratio (maximum heart rate during strain divided by minimum heart rate after strain) assesses the baroreflex arc, which depends on intact vagal signalling. Tilt table testing can reproduce orthostatic symptoms under controlled conditions and distinguish POTS from vasovagal syncope and orthostatic hypotension.
Heart rate variability analysis provides a non-invasive window into vagal function. The European Society of Cardiology’s thresholds remain clinically useful: SDNN below 50 ms indicates severely depressed autonomic function, while RMSSD below 15 ms suggests specific parasympathetic deficiency. A 2026 review by Wang and colleagues in Frontiers in Cardiovascular Medicine confirmed that low HRV carries a 32-45% higher risk of first cardiovascular events.
The full autonomic reflex screen — combining cardiovagal, adrenergic, and sudomotor testing — provides the most comprehensive assessment and can help localise whether the dysfunction is predominantly vagal, sympathetic, or both.
Management Principles
Treatment depends on the specific type, but several principles apply broadly. Volume expansion through increased fluid intake (2-3 litres daily) and salt supplementation (up to 10 grams daily for POTS) addresses the hypovolaemia common across several subtypes. Compression garments reduce venous pooling. Graduated exercise programmes — starting recumbent and progressing to upright — have the strongest evidence base for POTS specifically.
Pharmacological options include fludrocortisone for volume expansion, midodrine for vasoconstriction, and beta-blockers or ivabradine for heart rate control in POTS. For autoimmune subtypes, immunomodulatory therapy — intravenous immunoglobulin, plasmapheresis, or targeted immunosuppression — may address the underlying cause rather than just managing symptoms.
Vagus nerve stimulation (VNS) is under investigation as a potential therapeutic approach. The rationale is that stimulating the vagus nerve may help recalibrate the disrupted autonomic balance. Transcutaneous auricular VNS (taVNS) has shown preliminary benefits for heart rate variability and blood pressure regulation in small studies, though large-scale trials are needed.
When to Seek Specialist Evaluation
Recurrent unexplained fainting, persistent tachycardia on standing, exercise intolerance out of proportion to fitness level, and gastroparesis without clear cause all warrant referral to an autonomic specialist — typically a neurologist or cardiologist with autonomic expertise. Early diagnosis matters because many forms of dysautonomia are treatable, and delayed diagnosis often leads to years of unnecessary suffering and misdiagnosis.
Want to understand the nerve that controls your heart rate, digestion, and stress response — and what happens when it stops working properly? Get My Vagus Nerve & Me eBook for a complete guide to vagal anatomy, function, and evidence-based strategies for support.
